Invention Grant
- Patent Title: 1,8-naphthyridine compounds for the treatment of cancer
- Patent Title (中): 用于治疗癌症的1,8-萘啶化合物
-
Application No.: US12304750Application Date: 2007-06-12
-
Publication No.: US08124773B2Publication Date: 2012-02-28
- Inventor: Daniel C. Adelman , Marc J. Evanchik , Anantha Sudhakar , Jeffrey William Jacobs , Jeffrey A. Silverman
- Applicant: Daniel C. Adelman , Marc J. Evanchik , Anantha Sudhakar , Jeffrey William Jacobs , Jeffrey A. Silverman
- Applicant Address: US CA South San Francisco
- Assignee: Sunesis Pharmaceuticals, Inc.
- Current Assignee: Sunesis Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Jones Day
- International Application: PCT/US2007/013873 WO 20070612
- International Announcement: WO2007/146335 WO 20071221
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; C07D487/04
Abstract:
Compounds and compositions for treating, preventing or managing cancer are disclosed. The compositions provided herein comprise SNS-595 and N-desmethyl-SNS-595. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment using the compounds and compositions.
Public/Granted literature
- US20100029708A1 COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF CANCER Public/Granted day:2010-02-04
Information query
IPC分类:
